115 results on '"Klok, Frederikus A."'
Search Results
2. Antithrombotic Therapy for VTE Disease
3. Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review
4. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
5. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
6. Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
7. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study
8. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation
9. Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
10. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
11. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism
12. DOACs plasma levels in relation to clinical outcome. How far have we come?
13. Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism
14. Outcomes of venous thromboembolism care: future directions
15. The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism
16. Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
17. Atrial fibrillation, cancer and anticancer drugs
18. Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism
19. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review
20. Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice
21. Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study
22. The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study
23. Venous thromboembolism associated with estrogen–containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates
24. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
25. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma
26. Treatment and prevention of cancer-associated thrombosis in the Netherlands: a national survey
27. Non-invasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data
28. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
29. “ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
30. Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19
31. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
32. Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism
33. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation
34. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
35. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
36. Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
37. A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
38. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
39. Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer
40. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
41. Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress
42. Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
43. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
44. CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND LONG-TERM MORTALITY AFTER FIRST-TIME VENOUS THROMBOEMBOLISM: A POPULATION-BASED COHORT STUDY
45. First do no harm
46. Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis
47. Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism
48. Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008–2019: Retrospective analysis of epidemiological data
49. Vaccine-induced immune thrombotic thrombocytopenia
50. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.